Overview

Definition:
-Congenital glaucoma is a rare, severe, and often inherited disorder characterized by elevated intraocular pressure (IOP) that causes progressive damage to the optic nerve and visual field loss in infants
-It is typically diagnosed within the first year of life and presents with characteristic signs of tearing (epiphora) and photophobia.
Epidemiology:
-The incidence of primary congenital glaucoma (PCG) varies geographically, ranging from 1 in 10,000 to 1 in 30,000 live births
-It affects males slightly more than females
-Approximately 60% of cases are bilateral
-It can occur as an isolated condition (primary congenital glaucoma) or as part of a syndrome.
Clinical Significance:
-Prompt diagnosis and management of congenital glaucoma are crucial to prevent irreversible vision loss
-Untreated congenital glaucoma can lead to severe optic nerve damage, amblyopia, and blindness, significantly impacting a child's development and quality of life
-Understanding its presentation is vital for pediatricians and ophthalmologists.

Clinical Presentation

Symptoms:
-Excessive tearing (epiphora) in the affected eye(s)
-Increased sensitivity to light (photophobia), leading to involuntary eyelid closure (blepharospasm)
-Rubbing or pawing at the eyes
-Watery eyes
-Sometimes, a large, cloudy cornea (corneal edema).
Signs:
-Enlargement of the eyeball (buphthalmos) due to elevated IOP
-Corneal edema causing haziness and reduced visual acuity
-Stretching and pallor of the optic disc
-Increased axial length of the globe
-Fundus examination may reveal optic disc cupping, which can be difficult to assess in infants.
Diagnostic Criteria:
-Diagnosis is primarily based on the presence of characteristic clinical signs in an infant
-Key indicators include elevated IOP (>21 mmHg), corneal edema, Haab's striae (breaks in Descemet's membrane), optic nerve cupping, and ocular enlargement
-The triad of epiphora, photophobia, and blepharospasm is highly suggestive.

Diagnostic Approach

History Taking:
-A detailed birth history, including any signs of prematurity or distress
-Family history of glaucoma or similar eye conditions
-Parental observation of excessive tearing, light sensitivity, or rubbing of eyes
-Any history of trauma or infection to the eyes.
Physical Examination:
-A thorough ophthalmological examination under anesthesia is often necessary for accurate assessment in infants
-This includes measuring intraocular pressure (IOP) using a tonometer (e.g., Tono-Pen or Perkins applanation tonometer)
-Slit-lamp examination to assess the anterior chamber, cornea (for edema and Haab's striae), iris, and lens
-Fundus examination to evaluate the optic nerve head for cupping and pallor
-Measurement of corneal diameter and axial length.
Investigations:
-Intraocular pressure (IOP) measurement: Normal IOP in infants is typically between 10-20 mmHg
-Corneal diameter measurement: A corneal diameter >11 mm in infants may be indicative of glaucoma
-Ultrasound biomicroscopy (UBM) can assess anterior segment structures
-Optical coherence tomography (OCT) can help evaluate optic nerve head structure and nerve fiber layer thickness
-Genetic testing may be considered in suspected syndromic cases.
Differential Diagnosis:
-Infectious keratitis (e.g., bacterial or viral conjunctivitis with corneal involvement)
-Congenital corneal opacities (e.g., Peter's anomaly)
-Congenital nasolacrimal duct obstruction (dacryostenosis) presenting with tearing, but typically without photophobia or elevated IOP
-Uveitis
-Traumatic eye injuries.

Management

Initial Management:
-Immediate control of elevated IOP is paramount
-Medical management is typically initiated to reduce IOP before surgical intervention
-If IOP is very high and corneal edema is severe, a temporary patch or bandage contact lens may be used to protect the cornea.
Medical Management:
-Topical beta-blockers (e.g., Timolol 0.5% - 1 drop twice daily, cautiously in infants due to systemic absorption risks)
-Topical carbonic anhydrase inhibitors (e.g., Dorzolamide 2% - 1 drop twice daily)
-Topical alpha-agonists (e.g., Brimonidine 0.2% - 1 drop twice daily, use with caution in infants <2 years due to CNS depression risk)
-Topical miotics (e.g., Pilocarpine 1-2%) are generally avoided in congenital glaucoma due to potential for ciliary spasm and anterior segment ischemia.
Surgical Management:
-Goniotomy or trabeculotomy are the primary surgical procedures for congenital glaucoma, aiming to bypass or open the trabecular meshwork to improve aqueous outflow
-These are typically performed by a pediatric ophthalmologist
-If medical and initial surgical management fail, a trabeculectomy or glaucoma drainage device implantation may be considered
-Repeated surgeries may be necessary.
Supportive Care:
-Regular monitoring of IOP, corneal clarity, optic nerve status, and visual acuity
-Management of amblyopia through patching or atropine cycloplegia if present
-Counseling and support for parents regarding the chronic nature of the condition and long-term follow-up needs.

Complications

Early Complications:
-Hyphema (blood in the anterior chamber)
-Corneal dellen (stromal thinning)
-Infection following surgery
-IOP spikes post-operatively.
Late Complications:
-Progressive optic nerve damage and visual field loss despite treatment
-Development of amblyopia
-Ptosis
-Strabismus
-Cataract formation
-Myopia progression
-Recurrence of glaucoma
-Scarring and visual impairment from corneal edema.
Prevention Strategies:
-Early detection and prompt intervention are key
-Regular ophthalmic screening of infants, especially those with risk factors
-Adherence to prescribed medical and surgical management plans
-Careful monitoring for signs of disease progression or recurrence.

Prognosis

Factors Affecting Prognosis:
-The degree of optic nerve damage at presentation
-The success of initial surgical intervention
-The presence of associated ocular or systemic anomalies
-Age at diagnosis and treatment initiation
-Patient's adherence to follow-up and treatment.
Outcomes:
-With timely and appropriate management, many children with congenital glaucoma can achieve functional vision and prevent significant vision loss
-However, long-term follow-up is essential as the condition can be progressive
-Complete cure is rare, and management is often lifelong.
Follow Up:
-Lifelong regular ophthalmic examinations are crucial
-This includes IOP monitoring, optic nerve assessment, visual acuity testing, and corneal evaluation
-The frequency of follow-up will depend on the individual patient's response to treatment and disease stability.

Key Points

Exam Focus:
-Recognize the classic triad of tearing, photophobia, and blepharospasm in infants
-Understand the difference between primary congenital glaucoma and secondary forms
-Recall the initial medical management and primary surgical options (goniotomy/trabeculotomy)
-Differentiate from dacryostenosis
-Be aware of complications like buphthalmos and corneal edema.
Clinical Pearls:
-Always consider congenital glaucoma in an infant presenting with unexplained tearing and light sensitivity
-A simple corneal diameter measurement (>11mm) can be an early clue
-Intraocular pressure measurement under anesthesia is critical for definitive diagnosis
-The goal is to preserve optic nerve function and prevent amblyopia.
Common Mistakes:
-Attributing tearing solely to nasolacrimal duct obstruction without ruling out glaucoma
-Delaying referral to an ophthalmologist
-Inadequate IOP monitoring post-operatively
-Underestimating the risk of amblyopia development
-Using miotics routinely in congenital glaucoma.